pH News and Research

RSS

pH comes from the term “power of Hydrogen”, or the hydrogen ion concentration present in a given solution. It helps to measure the acidity or alkalinity of a substance.

Young binge drinkers more likely to have risk factors for cardiovascular disease

Young adults who frequently binge drink were more likely to have certain risk factors for cardiovascular disease than non-binge drinkers, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

27 Jun 2018

Study: 70,000 opioid-related deaths not reported owing to incomplete death certificates

Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health.

27 Jun 2018

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

In preclinical experiments, Laurie Harrington, Ph.D., and colleagues at the University of Alabama at Birmingham have discovered a subset of immune cells that create and sustain chronic inflammatory bowel disease.

27 Jun 2018

UPMC and Pitt announce launch of advanced genome sequencing center

UPMC and the University of Pittsburgh today announced the launch of an advanced genome sequencing center to support clinical diagnostics and research initiatives in precision medicine and immunotherapy.

27 Jun 2018

Many childhood cancer survivors show lack of concern for future well-being

A research team led by a St. Jude Children's Research Hospital epidemiologist has conducted the largest analysis to date of how adult survivors of childhood cancer view their health risk.

26 Jun 2018

Study finds byproduct of common prostate cancer drug can stimulate growth of tumor cells

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic. The findings may provide important information for identifying which patients potentially fare better when treated with an alternate therapy.

26 Jun 2018

Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for recurrent glioblastoma

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.

26 Jun 2018

Scientists discover new kind of small-cell lung cancer

Researchers have discovered a new kind of small-cell lung cancer. The discovery paves the way for developing personalized medicine approaches to target this previously unnoticed form of the disease.

26 Jun 2018

UVA research shows true nature of immune cells blamed in Alzheimer's

Immune cells commonly blamed in Alzheimer's and other neurodegenerative diseases are actually precision cleaning machines protecting the central nervous system, new research from the University of Virginia School of Medicine shows.

26 Jun 2018

CRISPR technique reduces repetitive behavior in fragile X syndrome mouse models

Scientists have used CRISPR-Cas9 gene editing to lessen some autism symptoms in mice with a form of fragile X syndrome, the most common known single-gene cause of autism spectrum disorder.

25 Jun 2018

Study examines link between gestational age at birth and ADHD symptoms in children

Early premature birth at less than 34 weeks was associated with symptoms of attention-deficit/hyperactivity disorder in preschool-age children and inattention symptoms in school-age children.

25 Jun 2018

Genetic subset of prostate cancer may benefit from combination checkpoint immunotherapy

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy released a study investigating the use of combination checkpoint immunotherapy in the treatment of a lethal form of advanced prostate cancer.

25 Jun 2018

Researchers use gene editing to reduce autism symptoms in mice

Researchers have used CRISPR-Cas9 gene editing to treat symptoms of autism in mice. It is hoped that the tool could one day be used to help humans.

25 Jun 2018

Maternal diabetes linked to increased risk of ASD in children

The risk of autism spectrum disorder was increased in children of mothers with the three main types of diabetes that complicate pregnancy, findings that add new information on type 1 diabetes and extend what is already known about type 2 and gestational diabetes.

25 Jun 2018

Scientists discover secret to success of antiviral gene

It's been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying.

25 Jun 2018

Overdose risk increases five-fold with concurrent opioid and benzodiazepine use

In the first 90 days of concurrent opioid and benzodiazepine use, the risk of opioid-related overdose increases five-fold compared to opioid-only use among Medicare recipients, according to a new study from the University of Pittsburgh School of Pharmacy, published today in JAMA Network Open

22 Jun 2018

DNA patterns in circulating blood cells can help identify spastic cerebral palsy

A Delaware team including Erin Crowgey, PhD, associate director of Bioinformatics with Nemours Biomedical Research, has published a study in the peer-reviewed journal BMC Bioinformatics, showing that DNA patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients.

22 Jun 2018

Researchers discover drug compound that inhibits movement of cancer cells

Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body.

22 Jun 2018

Unusual cell-to-cell communication in glioblastoma promotes aggressiveness and therapy resistance

A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

22 Jun 2018

Neural Analytics wins CE Mark for NeuralBot System

Neural Analytics, Inc., a medical robotics company developing and commercializing technologies to measure and track brain health, announced today that it received CE Mark for its NeuralBot™ System, a robotic assistance technology which automatically adjusts orientation and position of its ultrasound products under the guidance of a healthcare professional.

22 Jun 2018

pH News and Research

Further Reading

Young binge drinkers more likely to have risk factors for cardiovascular disease

Study: 70,000 opioid-related deaths not reported owing to incomplete death certificates

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

UPMC and Pitt announce launch of advanced genome sequencing center

Many childhood cancer survivors show lack of concern for future well-being

Study finds byproduct of common prostate cancer drug can stimulate growth of tumor cells

Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for recurrent glioblastoma

Scientists discover new kind of small-cell lung cancer

UVA research shows true nature of immune cells blamed in Alzheimer's

CRISPR technique reduces repetitive behavior in fragile X syndrome mouse models

Study examines link between gestational age at birth and ADHD symptoms in children

Genetic subset of prostate cancer may benefit from combination checkpoint immunotherapy

Researchers use gene editing to reduce autism symptoms in mice

Maternal diabetes linked to increased risk of ASD in children

Scientists discover secret to success of antiviral gene

Overdose risk increases five-fold with concurrent opioid and benzodiazepine use

DNA patterns in circulating blood cells can help identify spastic cerebral palsy

Researchers discover drug compound that inhibits movement of cancer cells

Unusual cell-to-cell communication in glioblastoma promotes aggressiveness and therapy resistance

Neural Analytics wins CE Mark for NeuralBot System

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo